Rocket


News + Filings
Transactions





Darvish Nissim

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/14/2023Chemomab Therapeutics Ltd.ANCNGrant 20.6k$1.70$35k 06/14/2023
03/16/2023Chemomab Therapeutics Ltd.ANCNGrant 6.9k$1.62$11.1k 06/14/2023
03/16/2023Chemomab Therapeutics Ltd.ANCNGrant 6.9k$1.62$11.1k 03/16/2023
03/11/2022Chemomab Therapeutics Ltd.ANCNPurchase 1.2k$4.28$5.1k 03/11/2022
03/07/2022Chemomab Therapeutics Ltd.ANCNGrant 6.8k$3.53$24.1k 03/16/2023
03/07/2022Chemomab Therapeutics Ltd.ANCNGrant 6.8k$3.53$24.1k 06/14/2023
03/07/2022Chemomab Therapeutics Ltd.ANCNGrantOption to Purchase American Depositary Shares6.8k$3.53$24.1k 03/07/2022
03/07/2022Chemomab Therapeutics Ltd.ANCNGrant 6.8k$3.53$24.1k 03/11/2022
04/19/2021Chemomab Therapeutics Ltd.ANCNGrant 11.9k$27.26$324k 03/07/2022
04/19/2021Chemomab Therapeutics Ltd.ANCNGrantOption to Purchase American Depositary Shares11.9k$27.26$324k 04/19/2021
04/19/2021Chemomab Therapeutics Ltd.ANCNGrant 11.9k$27.26$324k 06/14/2023
04/19/2021Chemomab Therapeutics Ltd.ANCNGrant 11.9k$27.26$324k 03/11/2022
04/19/2021Chemomab Therapeutics Ltd.ANCNGrant 11.9k$27.26$324k 03/16/2023
03/16/2021Chemomab Therapeutics Ltd.ANCNGrant 10.1k$0.80$8.1k 03/11/2022
10/30/20209 METERS BIOPHARMA, INC.INNTOther (acquisition)Common stock1.9M$0.00$0See footnote10/30/2020
06/30/20209 METERS BIOPHARMA, INC.INNTConversionSeries A Convertible Preferred Stock67.9k$0.00$0See Footnote06/30/2020
06/30/20209 METERS BIOPHARMA, INC.INNTConversionCommon stock6.8M$0.00$0See footnote 106/30/2020
05/04/20209 METERS BIOPHARMA, INC.INNTPurchaseSeries A Convertible Preferred Stock67.9k$0.00$0See Footnote05/04/2020
05/04/20209 METERS BIOPHARMA, INC.INNTPurchaseSeries A Convertible Preferred Warrant67.9k$0.00$0See Footnote05/04/2020
04/30/20209 METERS BIOPHARMA, INC.INNTGrantStock Option (Right to Buy)50k$0.70$35ksee footnote04/30/2020
10/28/2016Chemomab Therapeutics Ltd.ANCNGrant 10.1k$0.80$8.1k 06/14/2023
10/28/2016Chemomab Therapeutics Ltd.ANCNGrant 10.1k$0.80$8.1k 03/16/2023

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy